Chapter 2 Lecture (Dr. Dobson) TEST 1 Flashcards
Circulating DNA as Biomarker in Breast Cancer
- As the release of tumor-associated DNA (cell free DNA or cfDNA) into blood circulation is a common event in patients with cancer, screening of plasma or serum DNA may provide information on GENETIC AND EPIGENETIC PROFILES associated with breast cancer development, progression, and response to therapy.
- Quantitative testing of circulating DNA can reflect tumor burden, and MOLECULAR CHARACTERIZATION OF CIRCULATING DNA can reveal important tumor characteristics relevant to the choice of TARGETED THERAPIES in individual patients.
- Contrary to circulating DNA from blood that presents molecular changes in tumor DNA in real time, tissue biopsies can deliver only a spatially and temporally limited snapshot of the heterogeneous tumor.
- Analyses of circulating DNA might provide PROGNOSTIC AND PREDICTIVE INFORMATION and therefore advance personalized medicine.
- The release of cfDNA into the Bloodstream occurs by different sources, including the Primary Tumor, Tumor Cells that circulate in Peripheral Blood, Metastatic deposits present at distant sites, and normal cell types, such as HEMATOPOIETIC and STROMAL Cells.
- Thus, BOTH Tumor and Normal cfDNA Circulate in the Bloodstream of patients with Cancer. Its rapidly INCREASED Accumulation in Blood during Tumor Development is caused mainly by an EXCESSIVE DNA release by APOPTOTIC AND NECROTIC CELLS!!!!!!
Pathology Building Blocks
- Cells, tissues, organs disease
- Use all tools at your disposal ——-> microbiologic, immunologic, molecular, physiologic, pharmacologic
- Use this information in MOD and apply to systems pathology year 2
1) Etiology (cause)
2) Pathogenesis (sequence of events)
3) Morphology (structural alterations)
4) Clinical manifestations or functional derangements
Example - Colonic Adenocarcinoma
- The combination of MOLECULAR EVENTS that lead to Colonic Adenocarcinoma is heterogeneous and includes genetic and epigenetic abnormalities. At least two genetic pathways have been described.
- Epigenetic events, the most common of which is Methylation- induced gene SILENCING, may enhance progression along either pathway.
Breast Cancer
- Breast Cancer is associated with different Genetic and Epigenetic events, such as DNA Strand Integrity, Gene Amplifications, Gene Mutations, DNA Methylation, and Microsatellite Abnormalities
Pathology —> The Study of “Disease”
• Virtually all forms of disease start with molecular or structural
alterations in CELLS.
- Injury to cells and to extracellular matrix ultimately leads to TISSUE AND ORGAN INJURY, which determines the morphologic and clinical patterns of disease.
- First we have to have some understanding of the normal cellular response to stress and noxious stimuli.
cellular Responses to Stress and Toxic Insults
1) Adaptation
2) Injury
3) Death
Adaptation
A) An organ (Organism) is in a state of HOMEOSTATIS until it is “STRESSED”
B) There is a functional or structural response to changes in Physiologic State or Pathologic Stimuli
C) HYPERTROPHY,
- HYPERPLASIA
- ATROPHY
- METAPLASIA
D) Uterus Hypertrophy in Pregnancy
- ENDOMETRIAL Hyperplasia from Estrogen
- Muscle Atrophy from Disuse (Cast)
- Goblet Cell METAPLASIA in Barrett Esophagus
Cell Injury
- If the limits of Adaptive Responses are exceeded or if cells are exposed to Injurious Agent or stress, Deprives of essential Nutrients, or become compromised by MUTATIONS that affect essential Cellular Constituents, a sequence of events follows that is termed Cell Injury
a) Hypertrophy (Adaptation):
- Requires gene Activation, Protein Synthesis and New Organelles
b) Cell Injury:
- From DECREASED Blood Flow due t Atherosclerosis
c) Cell Death:
- Myocardial Infarction
* ** Cell Death can be due to Ischemia, Infection, Toxins
Cellular Adaptations to Stress
KEY CONCEPTS
1) HYPERTROPHY: INCREASED CELL AND ORGAN SIZE, often in response to increased workload; induced by growth factors produced in response to mechanical stress or other stimuli; occurs in tissues incapable of cell division
2) HYPERPLASIA: INCREASED CELL NUMBERS in response to hormones and other growth factors; occurs in tissues whose cells are able to divide or contain abundant tissue stem cells
3) ATROPHY: DECREASED CELL ADN ORGAN SIZE, as a result of decreased nutrient supply or disuse; associated with decreased synthesis of cellular building blocks and increased breakdown of cellular organelles
4) METAPLASIA: CHANGE IN PHENOTYPE OF DIFFERENTIATED CELLS, often in response to chronic irritation, that makes cells better able to withstand the stress; usually induced by altered differentiation pathway of tissue stem cells; may result in reduced functions or increased propensity for malignant transformation
Causes of Injury
- Oxygen deprivation (hypoxia/hypoxemia)
- Physical agents
- Chemical agents/drugs
- Infectious agents
- Immunologic reactions
- Genetic derangements
- Nutritional imbalance
PREVENTATIVE MEDICINE:
- Is the specialty of MEDICAL Practice that focuses on the Health of Individuals, Communities, and DEFINED Populations.
- Its goal is to Protect, Promote, and Maintain Health and well- being and to prevent Disease, Disability, and Death
Necrosis
- The Morphologic appearance of Necrosis as well as Necroptosis is the result of DENATURATION OF INTRACELLULAR PROTEINS and Enzymatic Digestion of the Lethally Injured Cell (May see under the Microscope or in the Blood)
NECROSIS
a) Feature:
- ENLARGED (Swelling)
b) Cell Size:
- Pyknosis —–> Karyorrhexis ———-> Karyolysis
c) Plasma Membrane:
- DISRUPTED
d) Cellular Contents:
- Enzymatic Digestion; May LEAK OUT OF CELL
e) Adjacent Inflammation:
- Frequent
f) Physiologic or Pathologic Role:
- Invariably Pathologic (Culmination of Irreversible Cell Injury)
Distinct Patterns of Necrosis
1) Coagulative Necrosis
2) Liquefactive Necrosis
3) Gangenous Necrosis
4) Caseous Necrosis
5) Fat Necrosis
Caseous Necrosis
• Caseous [ka ́se-us], Caseation [ka′′se-a ́shun]
• Type of necrosis associated with infection Tuberculosis
(MYCOBACTERIUM TUBERCULOSIS)
- Described as Yellow-White and “CHEESE-LIKE”
- On microscopic examination, the necrotic area appears as a structure less collection of fragmented or lysed cells and amorphous granular debris enclosed within a distinctive inflammatory border; this appearance is characteristic of a focus of inflammation known as a GRANULOMA.
What are the Mechanisms leading to Cell Injury?
- The cellular response to injurious stimuli depends on the NATURE of the injury, its DURATION, and its SEVERITY.
- The consequences of cell injury depend on the TYPE, STATE, and ADAPTABILITY of the Injured Cell.
- Cell injury results from different biochemical mechanisms acting on several ESSENTIAL CELLULAR COMPONENTS.
Principal Biochemical Mechanisms and Sites of Damage in Cell Injury
1) MITOCHONDRIAL DAMAGE:
a) DECR ATP
- Multiple Downstream Effects
b) INCR ROS
- Damage to Lipids, Proteins, DNA
2) ENTRY OF CA2+
a) INCR Mitochondrial Permeability
b) Activation of Multiple Cellular Enzymes
3) MEMBRANE DAMAGE:
a) Plasma Membrane
- Loss of CELLULAR COMPONENTS
b) Lysosomal Membrane
- Enzymatic DIGESTION of Cellular Components
4) Protein Misfolding, DNA Damage
a) Activation of PRO-APOPTOTIC PROTEINS